-
From the blog, an interview with Dr. Milo about genomics and personalized medicine...(let me know how I did) This was an invitation extended to me for the post from Helios. Helicos BiosSciences and Personalized Medicine - Featured Interview with Dr. Patrice Milos This week I had the opportunity to talk...
-
It should be the discretion of individual physicians, not insurance companies or pharmacies, to substitute a branded biologic for a biosimilar, which goes back to putting the physician in the decision making process, not the non clinical analyzers. While the search for "cheap" continues...
-
Dentists now are coming in to the fold of DNA genomics tests. This test is very specific to assess risk for periodontal disease, so as a younger patient, as chances are as we age if we are at risk we may already have this, this could be a good indicator for the dentist to have in the knowledge...
-
An interesting story on what a DNA report can reveal, in this case the woman has an X and a Y, instead of two Xs, like most females. It is somewhat rare but does exist with having internal testicles, and this produces extra high levels of estrogen, the the testosterone produced pretty much can't...
-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
-
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
-
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...
-
This is good, a genomics test that can give some preliminary results on whether or not statins will have an adverse effect before prescribing them. As the post states here, this is something that could certainly use some marketing to physicians. Zocor at 40 mg is a very common dosage and...
-
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
-
This gives a whole new meaning to the old redneck slang term of “swapping spit”. One more way to market oneself through genetics and single life. One question comes to mind, can they do this in California and New York? Even though the web site states this is specifically for dating...